PERIPHERAL T CELLS LYMPHOMA (PTCL)
Clinical trials for PERIPHERAL T CELLS LYMPHOMA (PTCL) explained in plain language.
Never miss a new study
Get alerted when new PERIPHERAL T CELLS LYMPHOMA (PTCL) trials appear
Sign up with your email to follow new studies for PERIPHERAL T CELLS LYMPHOMA (PTCL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Tough-to-Treat blood cancer: trial tests experimental drug cocktails
Disease control Recruiting nowThis study is testing new drugs and drug combinations for adults whose peripheral T-cell lymphoma has returned or not responded to previous treatments. It's a flexible 'platform trial' that can test multiple different treatments in small groups of patients. The main goals are to …
Matched conditions: PERIPHERAL T CELLS LYMPHOMA (PTCL)
Phase: PHASE1, PHASE2 • Sponsor: The Lymphoma Academic Research Organisation • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for Tough-to-Treat blood cancer
Disease control Recruiting nowThis study is testing a new combination of three drugs for adults with an aggressive type of blood cancer called peripheral T-cell lymphoma (PTCL) that has returned or not responded to prior treatment. About 26 patients will receive the drug combination for up to 6 cycles, follow…
Matched conditions: PERIPHERAL T CELLS LYMPHOMA (PTCL)
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC